OCTAGENE GMBH has a total of 45 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are NELSESTUEN GARY L, SLBIGEN INC and SHENZHEN GENO IMMUNE MEDICAL INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Australia | 6 | |
#3 | Canada | 4 | |
#4 | New Zealand | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | South Africa | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | Israel | 2 | |
#10 | Mexico | 2 | |
#11 | Poland | 2 | |
#12 | Bulgaria | 1 | |
#13 | Czechia | 1 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Estonia | 1 | |
#16 | Hungary | 1 | |
#17 | Norway | 1 | |
#18 | Serbia | 1 | |
#19 | Ukraine | 1 | |
#20 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Hauser Charlotte | 24 |
#2 | Lehnerer Michael | 18 |
#3 | Schroeder Carola | 17 |
#4 | Hoerster Andrea | 9 |
#5 | Casademunt Elisabeth | 9 |
#6 | Schroder Carola | 7 |
#7 | Bjoernstrup Kim | 6 |
#8 | Horster Andrea | 6 |
#9 | Hauser-Funke Charlotte | 5 |
#10 | Bjornstrup Kim | 2 |
Publication | Filing date | Title |
---|---|---|
CA2670003A1 | Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals | |
YU71002A | Production of recombinant blood clotting factors in human cell lines | |
EP1180364A1 | Steroid hormones as transfer agents | |
EP1136553A1 | Production of recombinant blood clotting factors in human cell lines | |
EP1151099A1 | Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |